A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

FDA's top vaccine official Vinay Prasad, MD, MPH, and others at the agency explained the recent pause on the use of the ...

A paper argued in favor of replacing diphenhydramine -- best known as Benadryl -- with newer antihistamines that have fewer side effects.

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

After emerging on the scene in the early 2000s, fracture liaison services (FLS) have solidified their place for preventing ...

An osteoanabolic agent should be the first choice treatment for patients at high or imminent risk for fracture, but once ...

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

Varshavski: However, now it's 2025, and we have a decade's worth of proof that RFK Jr. is in fact anti-vaccine. Kennedy: ...

The No Surprises Act may be reducing the amount of "surprise billing" patients face when they encounter an out-of-network ...

The EPA-targeted rules could prevent an estimated 30,000 deaths and save $275 billion each year they are in effect, according ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...